Provided by Tiger Trade Technology Pte. Ltd.

Cardiff Oncology, Inc.

0.9936
+0.05365.70%
Pre-market: 1.040.0486+4.89%09:03 EDT
Volume:593.65K
Turnover:563.34K
Market Cap:77.18M
PE:-1.68
High:1.01
Open:0.9401
Low:0.9026
Close:0.9400
52wk High:3.31
52wk Low:0.7566
Shares:77.67M
Float Shares:75.24M
Volume Ratio:0.82
T/O Rate:0.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5914
EPS(LYR):-0.6863
ROE:-94.08%
ROA:-46.73%
PB:2.91
PE(LYR):-1.45

Loading ...

Cardiff Oncology announces annual shareholder meeting

Reuters
·
Apr 24

Cardiff Oncology to present updated onvansertib Phase 2 mCRC data at ASCO 2026

Reuters
·
Apr 21

Cardiff Oncology to present preclinical data on onvansertib

TIPRANKS
·
Apr 18

Cardiff Oncology reports preclinical onvansertib-T-DXd synergy in HER2-low breast cancer models

Reuters
·
Apr 18

Cardiff Oncology CFO Joshua Muntner files initial beneficial ownership statement

Reuters
·
Apr 17

BRIEF-Cardiff Oncology Announces Key Leadership Appointments To Strengthen Executive Team For Next Phase Of Growth

Reuters
·
Apr 10

Cardiff Oncology names Mani Mohindru CEO, appoints Josh Muntner CFO

Reuters
·
Apr 10

Cardiff Oncology Inc - Appoints Josh Muntner as CFO Effective April 6 and Ajay Aggarwal as COO Effective April 27

THOMSON REUTERS
·
Apr 10

Cardiff Oncology Inc - Appoints Mani Mohindru as President and CEO; to Continue as Board Member

THOMSON REUTERS
·
Apr 10

Cardiff Oncology CEO Mark Erlander resigns as director after stepping down as CEO

Reuters
·
Apr 03

These 16 stocks are a short seller's dream - likely losers no matter what the market does

Dow Jones
·
Mar 29

These 16 stocks are a short seller's dream - likely losers no matter what the market does

Dow Jones
·
Mar 27

Noble Financial Sticks to Its Buy Rating for Cardiff Oncology (CRDF)

TIPRANKS
·
Mar 27

Analysts Are Bullish on These Healthcare Stocks: Cardiff Oncology (CRDF), CSPC Pharmaceutical Group (CHJTF)

TIPRANKS
·
Mar 26

Cardiff Oncology to host KOL webinar on first-line RAS-mutated metastatic colorectal cancer

Reuters
·
Mar 20

Cardiff Oncology to present onvansertib and T-DXd preclinical data at AACR Annual Meeting 2026

Reuters
·
Mar 19